+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Effect of N-formylated methionyl-phenylalanine (FMP) and methionyl-leucyl-phenylalanine (FMLP) on gut permeability. A model of local inflammatory process



Effect of N-formylated methionyl-phenylalanine (FMP) and methionyl-leucyl-phenylalanine (FMLP) on gut permeability. A model of local inflammatory process



Inflammation 9(4): 365-373



With the aim of elucidating inflammatory reactions in intestinal mucosa evoked by agents of microbial origin, the effect was assessed on intestinal permeability in the rat of two known chemoattractants for granulocytes and macrophages, N-formyl-methionyl-phenylalanine (FMP) and N-formyl-methionyl-leucyl-phenylalanine (FMLP). Fluoresceinated dextran (mol wt 3000 daltons) was used as a permeability marker. It was found that increasing concentrations of FMP enhanced the transmural passage up to a maximum at 2 X 10(-7)-2 X 10(-6)M. With FMLP the effect was greater than with FMP and measurable at 2 X 10(-9)-2 X 10(-8)M. The increased permeability was apparent 1-5 min after introduction of the peptides and prevailed during the 45-min measuring period. The bimodal response to the peptides is discussed in relation to different potential target-effector cells in the intestinal wall.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 039902752

Download citation: RISBibTeXText

PMID: 2416685


Related references

Effect of pectin on formyl methionyl-leucyl-phenylalanine (FMLP)-injured intestinal mucosa of rat. Journal of Nutritional Science and Vitaminology 38(2): 197-201, 1992

Pulmonary response of the guinea pig animal model to n-formyl-methionyl-leucyl-phenylalanine (FMLP) liquid aerosol. Proceedings Beltwide Cotton Production Research Conferences(1): 266-270, 1992

Effect of 1 week oral administration of formyl methionyl leucyl phenylalanine fmlp on the intestinal mucosa of rats. Gastroenterology 96(5 Part 2): A88, 1989

Rebamipide suppresses formyl-methionyl-leucyl-phenylalanine (fMLP)-induced superoxide production by inhibiting fMLP-receptor binding in human neutrophils. Journal of Pharmacology and Experimental Therapeutics 297(1): 388-394, 2001

Taxol inhibits N-formyl-methionyl-leucyl-phenylalanine (FMLP)-induced human neutrophil polarization and H2O2 production while decreasing [3H]FMLP binding. Agents and Actions 21(3-4): 278-280, 1987

Local motor responses to bradykinin and bacterial chemotactic peptide formyl-methionyl-leucyl-phenylalanine (FMLP) in the guinea-pig isolated renal pelvis and ureter. Journal of Urology 148(6): 1944-1950, 1992

In vivo chemotaxis of rat leukocytes to n formyl l methionyl l leucyl l phenylalanine fmlp. Comparative Immunology Microbiology & Infectious Diseases 10(1): 33-40, 1987

Taxol decreases n formyl methionyl leucyl phenylalanine fmlp binding to human neutrophils and inhibits fmlp induced neutrophil functions and cyclic amp elevation. Federation Proceedings 46(3): 1035, 1987

Antagonists of the formylated peptide chemoattractants: structure-activity comparisons with formyl-methionyl-leucyl-phenylalanine-OH. Kroc Foundation Series 14: 161-168, 1981

Hemodynamic and metabolic effects of intravenous formyl-methionyl-leucyl-phenylalanine (FMLP) in rabbits. In Vivo 11(2): 133-139, 1997

Enhancement of N-formyl-methionyl-leucyl-phenylalanine (fMLP) binding to isolated human neutrophils. Agents and Actions 26(3-4): 372-377, 1989

Effects of non-steroidal anti-inflammatory drugs on isolated human polymorphonuclear leukocytes (PMN): chemotaxis, superoxide production, degranulation and N-formyl-L-methionyl-L-leucyl-L-phenylalanine (FMLP) receptor binding. General Pharmacology 20(3): 329-334, 1989

Effect of endotoxin or N-formyl-methionyl-leucyl-phenylalanine (FMLP) on endotoxin sensitive (C3HeB. Proceedings (1): 297-300, 1995

Monocytes and neutrophils from tuberculosis patients are insensitive to anti-inflammatory effects triggered by the prototypic formyl peptide N-formyl-methionyl-leucyl-phenylalanine (FMLP). Clinical and Experimental Immunology 133(2): 267-274, 2003

Mechanisms and modulation of formyl-methionyl-leucyl-phenylalanine (fMLP)-induced Ca2+ mobilization in human neutrophils. International Immunopharmacology 1(7): 1341-1349, 2001